Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in photodynamic therapy report 2

被引:52
|
作者
Bressler, NM
机构
关键词
D O I
10.1016/S0002-9394(01)01237-5
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:168 / 169
页数:2
相关论文
共 50 条
  • [41] Clinicopathologic studies of age-related macular degeneration with classic subfoveal choroidal neovascularization treated with photodynamic therapy.
    Ghazi, NG
    Jabbour, NM
    De La Cruz, ZC
    Green, WR
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S933 - S933
  • [42] Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 5-year results of two randomized clinical trials with an open-label extension - TAP Report No. 8
    Kaiser, Peter K.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2006, 244 (09) : 1132 - 1142
  • [43] Optical coherence tomography following photodynamic therapy with verteporfin for subfoveal predominantly classic choroidal neovascularization
    Park, Carl H.
    Smith, Bradley T.
    Oh, Mila
    Fekrat, Sharon
    ANNALS OF OPHTHALMOLOGY, 2006, 38 (02) : 121 - 125
  • [44] Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin -: 1-year results of a randomized clinical trial -: VIP report no. 1
    Arnold, J
    Kilmartin, D
    Olson, J
    Neville, S
    Robinson, K
    Laird, A
    Richmond, C
    Farrow, A
    McKay, S
    Saperstein, DA
    Aaberg, TM
    Johnson, JB
    Waldron, R
    Loupe, D
    Gillman, J
    Myles, B
    Schachat, AP
    Bressler, NM
    Bressler, SB
    Nesbitt, P
    Porter, T
    Hawse, P
    Hartnett, M
    Eager, A
    Belt, J
    Cain, D
    Emmert, D
    George, T
    Herring, M
    McDonald, J
    Monés, J
    Corcóstegui, B
    Gilbert, M
    Duran, N
    Sisquella, M
    Nolla, A
    Margalef, A
    Miller, JW
    Gragoudas, ES
    Lane, AM
    Emmanuel, N
    Holbrook, A
    Evans, C
    Lord, US
    Walsh, DK
    Callahan, CD
    DuBois, JL
    Lewis, H
    Kaiser, PK
    Holody, LJ
    OPHTHALMOLOGY, 2001, 108 (05) : 841 - 852
  • [45] Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration
    Lazic, Ratimir
    Gabric, Nikica
    OPHTHALMOLOGY, 2007, 114 (06) : 1179 - 1185
  • [47] Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration - Three-year results of an open-label extension of 2 randomized clinical trials - TAP report No. 5
    Bressler, NM
    ARCHIVES OF OPHTHALMOLOGY, 2002, 120 (10) : 1307 - 1314
  • [48] Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration using verteporfin (Visudyne): Impact of lesion component on one-year visual outcomes - TAP report #2
    Lewis, H
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S531 - S531
  • [49] Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia - 2-year results of a randomized clinical Trial - VIP report no. 3
    Blinder, KJ
    Blumenkranz, MS
    Bressler, NM
    Bressler, SB
    Donati, G
    Lewis, H
    Lim, JI
    Menchini, U
    Miller, JW
    Mones, JM
    Potter, MJ
    Pournaras, C
    Reaves, A
    Rosenfeld, P
    Schachat, AP
    Schmidt-Erfurth, U
    Sickenberg, M
    Singerman, LJ
    Slakter, J
    Strong, HA
    Virgili, G
    Williams, GA
    OPHTHALMOLOGY, 2003, 110 (04) : 667 - 673
  • [50] Verteporfin ocular photodynamic therapy combined with macular scatter photocoagulation for occult or predominantly occult subfoveal neovascularization in age-related macular degeneration: A follow up
    Peyman, GA
    Ratnakaram, R
    Canakis, C
    Livir-Rallatos, C
    Conway, MD
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U691 - U691